| Reaction Details |
|---|
 | Report a problem with these data |
| Target | Kallikrein-5 |
|---|
| Ligand | BDBM50256260 |
|---|
| Substrate/Competitor | n/a |
|---|
| Meas. Tech. | ChEBML_1687662 |
|---|
| Ki | >50000±n/a nM |
|---|
| Citation |  Teufel, DP; Bennett, G; Harrison, H; van Rietschoten, K; Pavan, S; Stace, C; Le Floch, F; Van Bergen, T; Vermassen, E; Barbeaux, P; Hu, TT; Feyen, JHM; Vanhove, M Stable and Long-Lasting, Novel Bicyclic Peptide Plasma Kallikrein Inhibitors for the Treatment of Diabetic Macular Edema. J Med Chem61:2823-2836 (2018) [PubMed] Article |
|---|
| More Info.: | Get all data from this article, Assay Method |
|---|
| |
| Kallikrein-5 |
|---|
| Name: | Kallikrein-5 |
|---|
| Synonyms: | KLK5 | KLK5_HUMAN | Kallikrein 5 | SCTE | kallikrein-related peptidase 5 preproprotein |
|---|
| Type: | PROTEIN |
|---|
| Mol. Mass.: | 32031.72 |
|---|
| Organism: | Homo sapiens (Human) |
|---|
| Description: | EBI_12584 |
|---|
| Residue: | 293 |
|---|
| Sequence: | MATARPPWMWVLCALITALLLGVTEHVLANNDVSCDHPSNTVPSGSNQDLGAGAGEDARS
DDSSSRIINGSDCDMHTQPWQAALLLRPNQLYCGAVLVHPQWLLTAAHCRKKVFRVRLGH
YSLSPVYESGQQMFQGVKSIPHPGYSHPGHSNDLMLIKLNRRIRPTKDVRPINVSSHCPS
AGTKCLVSGWGTTKSPQVHFPKVLQCLNISVLSQKRCEDAYPRQIDDTMFCAGDKAGRDS
CQGDSGGPVVCNGSLQGLVSWGDYPCARPNRPGVYTNLCKFTKWIQETIQANS
|
|
|
|---|
| BDBM50256260 |
|---|
| n/a |
|---|
| Name | BDBM50256260 |
|---|
| Synonyms: | CHEMBL4094403 |
|---|
| Type | Small organic molecule |
|---|
| Emp. Form. | C76H105N19O19S3 |
|---|
| Mol. Mass. | 1684.958 |
|---|
| SMILES | CC(C)C[C@@H]1NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc2cnc[nH]2)NC[C@H](C)NC(=O)[C@H]2CSCc3cc(CSC[C@H](NC1=O)C(O)=O)cc(CSC[C@H](NC(C)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC1C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCNC(N)=N)C(=O)N2)c3 |r| |
|---|
| Structure | 
|
|---|
Search and Browse
